Description
Why It’s Done:
• To check if Mycobacterium tuberculosis responds to Pyrazinamide treatment.
• To detect resistance to Pyrazinamide, which is crucial for managing multidrug-resistant tuberculosis (MDR-TB).
• To ensure the selection of an effective antibiotic regimen for tuberculosis patients.
• To monitor the success of tuberculosis therapy and make adjustments if needed.
Preparation:
• No special patient preparation is generally required for this test.
• The test is performed on clinical specimens such as sputum or tissue samples collected from the patient.
• Patients should follow healthcare provider instructions carefully during sample collection to ensure accuracy.
• Inform the laboratory if the patient is already undergoing tuberculosis treatment, as it might influence test results.
